Mechanistic Insight into Cancer Aetiology and Therapeutic Management by Natural Metabolites

  • Vandana Singh
  • Deepak Kumar
  • Sheemona Chowdhary
  • Kunal Maniar
  • Meenu Narwal
  • Rajasri Bhattacharyya
  • Dibyajyoti Banerjee


The sudden and uncontrolled proliferation of cells is a common cause of mortality. Cancer is a multifactorial disorder which involves both exogenous and endogenous factors for initiation, promotion and progression. The interplay between genes and environment induces genetic and epigenetic alterations to cause chronic diseases including cancers. The management of cancer is far from addressing genetic and epigenetic alterations. The major limitation of current therapy is that it affects the non-targeted tissues also. In this respect, anticancer drugs which are derived from natural resources are considered as good leads for drug development. The natural products have shown anticancer activity in various types of cancer. Thus, the use of the natural product in cancer chemotherapy is gaining attention. In this chapter, the recent plant-derived secondary metabolites with potential for therapeutic management of cancer are discussed.


Malignancy Cancer aetiology Cancer hallmarks Plant-derived natural products Cancer therapies Cancer chemoprevention 



Cyclin-dependent kinase 1


Cyclooxygenase 1


Hepatitis B virus


Human immunodeficiency virus


Human papilloma virus


Insulin growth factor-1


Tumour microenvironment






Withaferin A


  1. Baudino TA (2015) Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol 12:3–20CrossRefGoogle Scholar
  2. Beremblum I, Shubik P (1947) The role of croton oil applications, associated with a single painting of a carcinogen, in tumor induction of the mouse’s skin. Br J Cancer 1:379–382CrossRefGoogle Scholar
  3. Bernabeu E, Cagel M, Lagomarsino E, Moretton M, Chiappetta DA (2017) Paclitaxel: what has been done and the challenges remain ahead. Int J Pharm 526:474–495CrossRefGoogle Scholar
  4. Chang HC, Chen ST, Chien SY, Kuo SJ, Tsai HT, Chen DR (2011) Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum Exp Toxicol 30:1657–1665CrossRefGoogle Scholar
  5. Cook JL (1999) Tobacco smoke: chemical carcinogenesis and genetic lesions. Ochsner J 1:130–135PubMedPubMedCentralGoogle Scholar
  6. Cooper GM (2000) The cell: a molecular approach, The Development and Causes of Cancer, 2nd edn. Sinauer Associates, Sunderland. Available from: Google Scholar
  7. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860CrossRefGoogle Scholar
  8. Cragg GM, Pezzuto JM (2016) Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract 25(Suppl 2):41–59CrossRefGoogle Scholar
  9. Ferreira AK, Meneguelo R, Neto SC, Chierice GO, Maria DA (2011) Synthetic phosphoethanolamine induces apoptosis through caspase-3 pathway by decreasing expression of Bax/Bad protein and changes cell cycle in melanoma. J Cancer Sci Ther 3:053–059CrossRefGoogle Scholar
  10. Fridlender M, Kapulnik Y, Koltai H (2015) Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci 6:799CrossRefGoogle Scholar
  11. Greenwell M, Rahman PK (2015) Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res 6:4103PubMedPubMedCentralGoogle Scholar
  12. Gutiérrez JB, Salsamendi AL (2001) Fundamientos de ciência toxicológica. Diaz de Santos, Madrid, pp 155–177Google Scholar
  13. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674CrossRefGoogle Scholar
  14. Hanahan D, Weinberg RA, Hanahan PD (2017) 2 biological hallmarks of cancerGoogle Scholar
  15. Herceg Z, Vaissière T (2011) Epigenetic mechanisms and cancer: an interface between the environment and the genome. Epigenetics 6:804–819CrossRefGoogle Scholar
  16. Institute of Medicine (US) Roundtable on Environmental Health Sciences, Research, and Medicine, Wilson S, Jones L, Couseens C, et al (2002) Cancer and the environment: gene-environment interaction. National Academies Press (US), Washington, DC. 3, The Links Between Environmental Factors, Genetics, and the Development of Cancer. Available from:
  17. Iqbal J, Abbasi BA, Mahmood T, Kanwal S, Ali B, Khalil AT (2017) Plant-derived anticancer agents: a green anticancer approach. Asian Pac J Trop Biomed 7:1129–1150CrossRefGoogle Scholar
  18. Kazanets A, Shorstova T, Hilmi K, Marques M, Witcher M (2016) Epigenetic silencing of tumor suppressor genes: paradigms, puzzles, and potential. Biochim Biophys Acta (BBA)-Rev Cancer 1865:275–288CrossRefGoogle Scholar
  19. Kim SH, Kaplan JA, Sun Y, Shieh A, Sun HL, Croce CM, Grinstaff MW, Parquette JR (2015) The self-assembly of anticancer camptothecin–dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy. Chem Eur J 21:101–105CrossRefGoogle Scholar
  20. Kulkarni SK, Dhir A (2008) Withania somnifera: an Indian ginseng. Prog Neuro-Psychopharmacol Biol Psychiatry 32:1093–1105CrossRefGoogle Scholar
  21. Lombardi D, Venturini S, Veronesi A (2011) Neutropenic enterocolitis as possible complication of Docetaxel and Epirubicin chemotherapy for breast cancer: report of 3 cases. J Cancer Sci Ther 3:186–187Google Scholar
  22. Martin TA, Ye L, Sanders AJ, Lane J Jiang WG (2013) Cancer invasion and metastasis: molecular and cellular perspective. In Madame curie bioscience database [Internet]. Landes Bioscience, Austin; 2000–2013. Available from:
  23. Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H (2017) Combination therapy in combating cancer. Oncotarget 8:38022CrossRefGoogle Scholar
  24. Moudi M, Go R, Yien CY, Nazre M (2013) Vinca alkaloids. Int J Prev Med 4:1231PubMedPubMedCentralGoogle Scholar
  25. Nitiss JL (2009) Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 9:338CrossRefGoogle Scholar
  26. Oliveira PA, Colaço A, Chaves R, Guedes-Pinto H, De-La-Cruz P, Luis F, Lopes C (2007) Chemical carcinogenesis. An Acad Bras Cienc 79:593–616CrossRefGoogle Scholar
  27. Park YJ, Wen J, Bang S, Park SW, Song SY (2006) [6]-gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med J 47:688–697CrossRefGoogle Scholar
  28. Parsa N (2012) Environmental factors inducing human cancers. Iran J Public Health 41:1PubMedPubMedCentralGoogle Scholar
  29. Rastogi RP, Kumar A, Tyagi MB, Sinha RP (2010) Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids 2010:2010Google Scholar
  30. Ribatti D, Guidolin D, Conconi MT, Nico B, Baiguera S, Parnigotto PP, Vacca A, Nussdorfer GG (2003) Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene 22:6458CrossRefGoogle Scholar
  31. Saeki H, Sugimachi K (2001) Carcinogenic risk factors. Jpn Med Assoc J 44:245–249Google Scholar
  32. Sarkar A, Bhattacharjee S, Mandal DP (2015) Induction of apoptosis by eugenol and capsaicin in human gastric cancer AGS cells: elucidating the role of p53. Asian Pac J Cancer Prev 16:6753–6759CrossRefGoogle Scholar
  33. Seca AM, Pinto DC (2018) Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci 19:263CrossRefGoogle Scholar
  34. Shukla S, Meeran SM, Katiyar SK (2014) Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett 355:9–17CrossRefGoogle Scholar
  35. Stan SD, Hahm ER, Warin R, Singh SV (2008) Withaferin A causes FOXO3aand Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res 68:7661–7669CrossRefGoogle Scholar
  36. Steward WP, Brown K (2013) Cancer chemoprevention: a rapidly evolving field. Br J Cancer 109:1CrossRefGoogle Scholar
  37. Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C (2015) Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 35:645–651PubMedGoogle Scholar
  38. Vanita P, Subrahmanyam V, Jhansi K (2011) A short note on cancer. J Carcinogene Mutagene 2:128. CrossRefGoogle Scholar
  39. vel Szic KS, de Beeck KO, Ratman D, Wouters A, Beck IM, Declerck K, Heyninck K, Fransen E, Bracke M, De Bosscher K, Lardon F (2014) Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS One 9:e87850CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Vandana Singh
    • 1
  • Deepak Kumar
    • 1
  • Sheemona Chowdhary
    • 1
  • Kunal Maniar
    • 2
  • Meenu Narwal
    • 3
  • Rajasri Bhattacharyya
    • 1
  • Dibyajyoti Banerjee
    • 1
  1. 1.Department of Experimental Medicine & BiotechnologyPostgraduate Institute of Medical Education & ResearchChandigarhIndia
  2. 2.Department of PharmacologyPostgraduate Institute of Medical Education & ResearchChandigarhIndia
  3. 3.Department of BiotechnologyMaharishi Markandeshwar (Deemed to be University)AmbalaIndia

Personalised recommendations